Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FIXIT: TTP889 for VTE prophylaxis after hip fracture surgery
NCT00119457Phase 2Completed
- Sponsor
- vTv Therapeutics
- Start
- Jan 2005
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of TTP889 in venous thromboembolism (VTE), sponsored by vTv Therapeutics. Started Jan 2005; status: completed.
02
Drugs
TTP889
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT00119457.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00119457.